Efficacy and Safety of Human Intravenous Immunoglobulin 10% (Panzyga®) in Patients with Primary Immunodeficiency Diseases: a Two-Stage, Multicenter, Prospective, Open-Label Study

人免疫球蛋白10%静脉注射液（Panzyga®）治疗原发性免疫缺陷病患者的疗效和安全性：一项两阶段、多中心、前瞻性、开放标签研究